Production (Stage)
Cadrenal Therapeutics, Inc.
CVKD
$13.35
-$0.35-2.56%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 11.72% | 19.23% | -52.09% | 55.96% | 63.00% |
| Total Receivables | -- | 2.69% | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 95.92% | -19.27% | 13.70% | -18.80% | -28.50% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -94.93% | -- | -- | -- | -- |
| Total Current Assets | 13.04% | 19.08% | -49.64% | 54.68% | 58.31% |
|
|
|||||
| Total Current Assets | 13.04% | 19.08% | -49.64% | 54.68% | 58.31% |
| Net Property, Plant & Equipment | -71.69% | -70.39% | -89.93% | -72.58% | -57.44% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Assets | 12.84% | 18.83% | -49.75% | 53.34% | 57.26% |
|
|
|||||
| Total Accounts Payable | 219.28% | 798.09% | 250.60% | 872.47% | 234.78% |
| Total Accrued Expenses | 27.45% | 85.13% | 93.47% | 156.01% | 70.26% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -91.20% | -63.49% | -34.48% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 114.90% | 224.59% | 124.79% | 291.37% | 113.22% |
|
|
|||||
| Total Current Liabilities | 114.90% | 224.59% | 124.79% | 291.37% | 113.22% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 114.90% | 224.59% | 123.91% | 282.38% | 105.45% |
|
|
|||||
| Common Stock & APIC | 55.63% | 45.68% | 10.03% | 43.90% | 43.71% |
| Retained Earnings | -76.69% | -70.67% | -54.63% | -48.38% | -40.77% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -1.28% | -3.29% | -60.98% | 25.71% | 52.32% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -1.28% | -3.29% | -60.98% | 25.71% | 52.32% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -1.28% | -3.29% | -60.98% | 25.71% | 52.32% |
|
|
|||||